Safety and feasibility of adding tumor debulking to palliative chemotherapy in multi-organ metastatic colorectal cancer: The ORCHESTRA trial.

Elske C. Gootjes,Eric P. van der Stok,Lotte Bakkerus,Tineke E. Buffart,B.M. Zonderhuis,Martijn R. Meijerink,C.J.A. Haasbeek,Peter M. van de Ven,Albert J. ten Tije,Jan Willem B. de Groot,Sandra A. Radema,Esther van Meerten,Joost J. Nuyttens,Cornelis Verhoef,Henk M.W. Verheul

Safety and feasibility of adding tumor debulking to palliative chemotherapy in multi-organ metastatic colorectal cancer: The ORCHESTRA trial.

2017

Elske C. Gootjes
Eric P. van der Stok
Lotte Bakkerus
Tineke E. Buffart
B.M. Zonderhuis
Martijn R. Meijerink
C.J.A. Haasbeek
Peter M. van de Ven
Albert J. ten Tije
Jan Willem B. de Groot
Sandra A. Radema
Esther van Meerten
Joost J. Nuyttens
Cornelis Verhoef
Henk M.W. Verheul

3553Background: For selected patients with oligometastatic colorectal cancer (mCRC), local treatment of metastases is standard of care based on retrospective reports showing long term survival rate...

Keywords:

Tumor Debulking
Pathology
Oncology
Colorectal cancer
Internal medicine
Chemotherapy
Medicine
multi organ
standard of care
Physical therapy
palliative chemotherapy
long term survival

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations